KAMRHO (D) IV

Indications:

• Antepartum suppression of Rh immunization in Rho(D)-negative women
• Treatment for patients with chronic or acute ITP
• Treatment for patients with ITP secondary to HIV infection, in clinical situations requiring an increase in platelet count to prevent excessive hemorrhaging.

Active Ingredient: Rho(D) Immunoglobulin (Human)
Strength: 1500 IU (300 mcg)
Volume: 2 ml
Method of Administration: Ready-to-use solution for intravenous injection

Product photo